This site is intended for UK healthcare professionals only

Diabetes Professional Care
15-16 October 2024, Olympia London

The UK's leading event for the entire team involved in the prevention, treatment and management of diabetes and its related conditions.

Are you a UK healthcare professional?

We are unfortunately unable to allow patients to attend Diabetes Professional Care

If you would like more information on general practice or primary care, please refer to the NHS website.

Visit the NHS website

Legal Notice

DIABETES PROFESSIONAL CARE IS SUPPORTED BY THE PHARMACEUTICAL AND MED TECH INDUSTRIES VIA GRANTS, SPONSORSHIP, AND EXHIBITION PACKAGES. SESSIONS DELIVERED WITH INPUT FROM OUR SUPPORTERS WILL ALWAYS BE MARKED ON THE PROGRAMME.
A FULL LIST OF CONFIRMED SUPPORTERS FOR DIABETES PROFESSIONAL CARE CAN BE FOUND HERE.
 

News

Subpage Hero

     

06 Dec 2022

Study will identify children at high risk of type 1 diabetes

Study will identify children at high risk of type 1 diabetes

A new trial screening programme is recruiting 20,000 children aged between three and 13 in the UK to identify youngsters at high risk of type 1 diabetes.

The ELSA (EarLy Surveillance for Autoimmune diabetes) study is the first research of its kind in the UK and could lead to the development of a UK-wide screening programme.

The programme, which was launched on World Diabetes Day, will assess children’s risk of type 1 diabetes through a combination of finger prick and venous blood tests.

Children identified as being at high risk, and their families, will be given support to ensure they receive the earliest, safest diagnosis possible.

Those identified as being at high risk of type 1 diabetes may also be given access to clinical trials testing innovations in type 1 diabetes treatment which may prevent or delay the condition.

Parents or guardians of those children found to be at risk of type 1 diabetes will be invited to an education session.

The national research team is led by researchers at the University of Birmingham, Parth Narendran, Professor of Diabetes Medicine, and Dr Lauren Quinn, Clinical Research Fellow.

The study is being funded by Diabetes UK in partnership with JDRF.

The ELSA study team said: “We are extremely grateful to our funders JDRF and Diabetes UK.

“We hope ELSA will lead to the roll-out of a type 1 diabetes early detection programme for children in the UK and encourage families with children at a suitable age to consider taking part.”

To find out more about the ELSA study, visit https://elsadiabetes.nhs.uk/take-part/
View all News
Loading

Partners

Education Partner

Education Partner

Event Partner

Event Partner

Event Partner

Event Partner

Event Partner

Event Partner

Event Partner

Event Partner

Event Partner

Media Partner